Reinhard Schneppenheim
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications
The search for the underlying mutations causing VWD in 13 Venezuelan families.
Journal: Thrombosis research
Published: June 01, 2023
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
Journal: Journal of thrombosis and haemostasis : JTH
Published: September 15, 2022
Structure and dynamics of the von Willebrand Factor C6 domain.
Journal: Journal of structural biology
Published: July 21, 2022
Hereditary thrombotic thrombocytopenic purpura and COVID-19: Impacts of vaccination and infection in this rare disease.
Journal: Research and practice in thrombosis and haemostasis
Published: April 08, 2022
A conformational transition of the D'D3 domain primes von Willebrand factor for multimerization.
Journal: Blood advances
Published: January 04, 2022
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study.
Journal: Journal of thrombosis and haemostasis : JTH
Published: September 21, 2021
Genetic and Clinical Predictors of Left Atrial Thrombus: A Single Center Case-Control Study.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: June 29, 2021
Evidence for a low-penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6.
Journal: Pediatric blood & cancer
Published: February 13, 2021
Gain-of-Function Variant p.Pro2555Arg of von Willebrand Factor Increases Aggregate Size through Altering Stem Dynamics.
Journal: Thrombosis and haemostasis
Published: December 31, 2020
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
Journal: Blood advances
Published: September 14, 2020
Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK).
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 02, 2020
Comparison of von Willebrand factor platelet-binding activity assays: ELISA overreads type 2B with loss of HMW multimers.
Journal: Journal of thrombosis and haemostasis : JTH
Published: February 27, 2020
Last Updated: 09/26/2026